GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MediClin AG (XTER:MED) » Definitions » Price-to-Free-Cash-Flow

MediClin AG (XTER:MED) Price-to-Free-Cash-Flow : 3.30 (As of Apr. 29, 2024)


View and export this data going back to 2000. Start your Free Trial

What is MediClin AG Price-to-Free-Cash-Flow?

As of today (2024-04-29), MediClin AG's share price is €2.82. MediClin AG's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.86. Hence, MediClin AG's Price-to-Free-Cash-Flow Ratio for today is 3.30.

The historical rank and industry rank for MediClin AG's Price-to-Free-Cash-Flow or its related term are showing as below:

XTER:MED' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 1.96   Med: 13.69   Max: 792.86
Current: 3.3

During the past 13 years, MediClin AG's highest Price-to-Free-Cash-Flow Ratio was 792.86. The lowest was 1.96. And the median was 13.69.

XTER:MED's Price-to-Free-Cash-Flow is ranked better than
93.26% of 356 companies
in the Healthcare Providers & Services industry
Industry Median: 17.98 vs XTER:MED: 3.30

MediClin AG's Free Cash Flow per Share for the three months ended in Dec. 2023 was €0.33. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was €0.86.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of MediClin AG was 370.20% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -24.20% per year.

During the past 13 years, MediClin AG's highest 3-Year average Free Cash Flow per Share Growth Rate was 87.30% per year. The lowest was -60.10% per year. And the median was -18.65% per year.


MediClin AG Price-to-Free-Cash-Flow Historical Data

The historical data trend for MediClin AG's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediClin AG Price-to-Free-Cash-Flow Chart

MediClin AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.92 1.98 2.87 19.89 3.22

MediClin AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.89 22.80 10.89 8.25 3.22

Competitive Comparison of MediClin AG's Price-to-Free-Cash-Flow

For the Medical Care Facilities subindustry, MediClin AG's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MediClin AG's Price-to-Free-Cash-Flow Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MediClin AG's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where MediClin AG's Price-to-Free-Cash-Flow falls into.



MediClin AG Price-to-Free-Cash-Flow Calculation

MediClin AG's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=2.82/0.855
=3.30

MediClin AG's Share Price of today is €2.82.
MediClin AG's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.86.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

MediClin AG  (XTER:MED) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


MediClin AG Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of MediClin AG's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


MediClin AG (XTER:MED) Business Description

Traded in Other Exchanges
Address
Okenstrasse 27, Offenburg, DEU, 77652
MediClin AG is a company engaged in operating hospitals. It is focused on providing services in the areas of neurosciences and psychological sciences as well as orthopedics in Germany. The hospitals are acute-care hospitals providing basic, standard, and specialized care, as well as specialist clinics for medical rehabilitation. The operating segments of the group are Post-acute, Acute and Other activities. It generates majority of the revenue from the Post-acute segment in which the firm offers services in the fields of subsequent nursing treatment and curative treatment. Subsequent nursing treatment starts after acute care treatment and includes all medical measures required to facilitate the healing process and return the patient to a functioning state.